Dupilumab in Patients with Corticosteroid-Dependent Severe Asthma: Efficacy and Safety Results from the Randomized, Double-Blind, Placebo-Controlled Phase 3 LIBERTY ASTHMA VENTURE Study

被引：0

作者：

Rabe, K. F. ^{[1
,2
]}

Nair, P. K. ^{[3
,4
]}

Brusselle, G. G. ^{[5
]}

Maspero, J. F. ^{[6
]}

Castro, M. ^{[7
]}

Zhu, H. ^{[8
]}

Staudinger, H. ^{[8
]}

Pirozzi, G. ^{[8
]}

Antoni, C. ^{[8
]}

Amin, N. ^{[9
]}

Ruddy, M. ^{[9
]}

Akinlade, B. ^{[9
]}

Khan, A. ^{[10
]}

Chao, J. ^{[9
]}

Graham, N. M. ^{[9
]}

Teper, A. ^{[8
]}

机构：

[1] LungenClin Grosshansdorf, Kiel, Germany

[2] Univ Kiel, Kiel, Germany

[3] McMaster Univ, Hamilton, ON, Canada

[4] St Josephs Healthcare, Hamilton, ON, Canada

[5] Ghent Univ Hosp, Ghent, Belgium

[6] Fdn CIDEA, Buenos Aires, DF, Argentina

[7] Washington Univ, Sch Med, St Louis, MO USA

[8] Sanofi, Bridgewater, NJ USA

[9] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[10] Sanofi, Chilly Mazarin, France

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A7712

引用

页数：2

共 50 条

[1] Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial
Davidescu, Lavinia
Ursol, Grigoriy
Korzh, Oleksii
Deshmukh, Vikranth
Kuryk, Lesia
Nortje, Monja-Marie
Godlevska, Olga
Devouassoux, Gilles
Khodosh, Eduard
Israel, Elliot
Moussy, Alain
Mansfield, Colin
Hermine, Olivier
Chanez, Pascal
JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 737 - 747
[2] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
Busse, William W.
Maspero, Jorge F.
Rabe, Klaus F.
Papi, Alberto
Wenzel, Sally E.
Ford, Linda B.
Pavord, Ian D.
Zhang, Bingzhi
Staudinger, Heribert
Pirozzi, Gianluca
Amin, Nikhil
Akinlade, Bolanle
Eckert, Laurent
Chao, Jingdong
Graham, Neil M. H.
Teper, Ariel
ADVANCES IN THERAPY, 2018, 35 (05) : 737 - 748
[3] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
William W. Busse
Jorge F. Maspero
Klaus F. Rabe
Alberto Papi
Sally E. Wenzel
Linda B. Ford
Ian D. Pavord
Bingzhi Zhang
Heribert Staudinger
Gianluca Pirozzi
Nikhil Amin
Bolanle Akinlade
Laurent Eckert
Jingdong Chao
Neil M. H. Graham
Ariel Teper
Advances in Therapy, 2018, 35 : 737 - 748
[4] Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma
Lock, SH
Kay, AB
Barnes, NC
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) : 509 - 514
[5] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Busse, W. W.
Wenzel, S. E.
Meltzer, E. O.
Kerwin, E. M.
Liu, M. C.
Zhang, N.
Chon, Y.
Lin, J.
Lin, S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
[6] Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials
Bernstein, Jonathan A.
Virchow, J. Christian
Murphy, Kevin
Maspero, Jorge Fernando
Jacobs, Joshua
Adir, Yochai
Humbert, Marc
Castro, Mario
Marsteller, Douglas A.
McElhattan, Jennifer
Hickey, Lisa
Garin, Margaret
Vanlandingham, Rebecca
Brusselle, Guy
LANCET RESPIRATORY MEDICINE, 2020, 8 (05): : 461 - 474
[7] Efficacy of dupilumab in patients with oral corticosteroid (OCS)-dependent, severe asthma with and without an allergic phenotype: phase 3 LIBERTY ASTHMA VENTURE
Brusselle, Guy
Papi, Alberto
Chipps, Bradley E.
Msihid, Jerome
Jacob-Nara, Juby A.
Deniz, Yamo
Rowe, Paul
Gall, Rebecca
Ortiz, Benjamin
Djandji, Michel
Radwan, Amr
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[8] Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot study
Gotfried, MH
Jung, R
Messick, CR
Rubinstein, I
Garey, KW
Rodvold, KA
Danziger, LH
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2004, 65 (01): : 1 - 12
[9] Efficacy and Safety of Dupilumab in Patients From China With Persistent Asthma: A Subgroup Analysis of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study
Zhang, Q.
Zhong, N.
Fang, H.
Zhu, S.
Wang, Z.
Zhao, L.
Laws, E.
Mannent, L.
Wang, Y.
Li, V.
Li, A.
Hu, C.
Lederer, D. J.
Abdulai, R. M.
Robinson, L.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[10] Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials
Hanania, Nicola A.
Noonan, Michael J.
Corren, Jonathan
Korenblat, Phillip
Zheng, Yanan
Putnam, Wendy
Murray, Elaine
Abelardo, Connie
Scheerens, Heleen
Maciuca, Romeo
Gray, Sarah
Doyle, Ramona
McClintock, Dana
Matthews, John G.
Yen, Karl
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB402 - AB402

← 1 2 3 4 5 →